Pentixapharm Holding AG
A clinical-stage company developing first-in-class radiopharmaceuticals.
PTP | F
Overview
Corporate Details
- ISIN(s):
- DE000A383RV0 (+1 more)
- LEI:
- 3912005VBOVXNDXEQZ36
- Country:
- Germany
- Address:
- Robert-Rössle-Straße, 10, 13125 Berlin
- Website:
- https://www.pentixapharm.com/
- Sector:
- Manufacturing
Description
Pentixapharm Holding AG is a clinical-stage company focused on developing first-in-class radiopharmaceuticals. The company's research and development centers on CXCR4 ligand-based compounds for diagnostic and therapeutic applications. Its clinical pipeline features two drug candidates that are ready for Phase III trials. One of its lead assets is the radiodiagnostic candidate 68Ga-PentixaFor, which is being prepared for a Phase 3 study for applications in hypertension. The company's core CXCR4 compound has been extensively studied, administered to over 2,000 patients, and is the subject of more than 150 scientific publications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-03 08:00 |
Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radi…
|
English | 10.2 KB | ||
| 2025-11-27 10:29 |
Pentixapharm Holding AG: Eckert Wagniskapital und Fruhphasenfinanzierung GmbH, …
|
English | 6.4 KB | ||
| 2025-11-12 08:00 |
Pentixapharm Publishes 9-Month Figures for 2025
|
English | 7.6 KB | ||
| 2025-11-12 00:00 |
Q3 statement / Q3 financial report 2025
|
English | 941.4 KB | ||
| 2025-11-10 08:00 |
Pentixapharm to Report Third Quarter and First Nine Months 2025 Financial Resul…
|
English | 7.9 KB | ||
| 2025-11-06 19:55 |
Pentixapharm Holding AG: Pentixapharm significantly reduces projected loss for …
|
English | 7.1 KB | ||
| 2025-11-06 10:28 |
Pentixapharm Holding AG: Eckert Wagniskapital und Fruhphasenfinanzierung GmbH, …
|
English | 6.4 KB | ||
| 2025-11-03 10:52 | English | 3.9 KB | |||
| 2025-10-23 22:12 |
Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure
|
English | 8.6 KB | ||
| 2025-10-23 20:59 |
Pentixapharm Holding AG: Pentixapharm Focuses Development on Advanced Clinical …
|
English | 7.5 KB | ||
| 2025-10-06 11:00 |
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New …
|
English | 10.5 KB | ||
| 2025-09-26 08:00 |
Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acut…
|
English | 11.3 KB | ||
| 2025-09-16 15:19 |
Pentixapharm Holding AG: Eckert Wagniskapital und Fruhphasenfinanzierung GmbH, …
|
English | 6.1 KB | ||
| 2025-09-15 11:49 |
Pentixapharm Holding AG: Dr. Andreas Eckert, buy
|
English | 5.8 KB | ||
| 2025-08-06 00:00 |
Half-yearly financial report 2025
|
English | 723.4 KB |
Automate Your Workflow. Get a real-time feed of all Pentixapharm Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pentixapharm Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pentixapharm Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
